Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Evergold Announces Closing of $350,000 Convertible Debenture Private Placement with CJ “Charlie” Greig; Drilling at DEM is Underway
-
From The Brand That Does Baby Luxury Best, Nuna Unveils Its Exclusive Wardrobe Collection
-
Calumet Reports Third Quarter 2025 Results
-
Onex Reports Third Quarter 2025 Results
-
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
MADD Canada Unveils Roadside Memorial Sign in Trenton in Honour of Rebecca Beatty Killed in Impaired Driving Crash
-
Kezar Life Sciences Announces Presentation of PORTOLA Data at the American Association for the Study of Liver Disease (AASLD) – The Liver Meeting® 2025
-
Uranium Energy Corp Applauds U.S. Government's Designation of Uranium as a Critical Mineral
-
Corra Group Explores AI Innovations and Industry Trends at PBSA Annual Conference
-
Ambetter from Fidelis Care Offers Health Insurance in New York State in 2026
-
Boralex announces its third quarter results and commissioning of large-scale projects in Canada
-
VERSABANK TO PARTICIPATE IN THE KBW FINTECH PAYMENTS CONFERENCE IN NEW YORK CITY ON NOVEMBER 11-13, 2025
-
Lagoon Furniture at BDNY 2025 | Stylish & Durable Hospitality Design
-
T.D. Jakes Teams Up With iHeartMedia to Launch "NXT Chapter," A Weekly Podcast Helping to Co-Author New Pages of America's Collective Story
-
Gundry MD Launches the Total Body Transformation Course: A Breakthrough Weight Loss Program to Help People Look and Feel Years Younger
-
Wayfair Appoints Retail Industry Leader Hal Lawton to Board of Directors
-
Notice of Annual General Meeting to Be Held on December 9, 2025
-
HS Hyosung Advanced Materials Achieves Top 1% Platinum Medal for the second consecutive year in Global ESG Assessment
-
Sylvamo Releases Third Quarter Earnings
-
Canopy Growth Reports Second Quarter Fiscal 2026 Financial Results; Company Continues to Strengthen Financial Performance with Improving Adjusted EBITDA, Disciplined Cost Management, and a Stronger Ba
-
Enbridge Reports Strong Third Quarter Results, Announces Accretive Investments and Reaffirms 2025 Financial Guidance
-
Alebund Presents Phase 3 Trial Results of AP301 at the American Society of Nephrology (ASN) 2025 Congress
-
Duke Energy reports third-quarter 2025 financial results
-
TaskUs Announces Fiscal Third Quarter 2025 Results
-
Donaldson Company to Present at the Baird 2025 Global Industrial Conference
-
THE WENDY'S COMPANY REPORTS THIRD QUARTER 2025 RESULTS
-
agilon Announces Receipt of Notice of Non-Compliance with the NYSE Continued Listing Standards
-
Introducing BRAWN™ — Structural Solutions for Stronger Factory-Built Products
-
Bring Home the Sound of Sphere With “The Wizard of Oz at Sphere: The Soundtrack”
-
Mobileye Announces Participation in Upcoming Fourth Quarter 2025 Investor Conferences
-
American Bancorp Inc. Completes Merger with New Republic Partners Inc., Expanding Presence Across the Southeast
-
Team Velocity Sets Benchmark With Apollo Dealer Sites Passing Google Core Web Vitals
-
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
1stDibs Reports Third Quarter 2025 Financial Results
-
NHC Reports Third Quarter 2025 Earnings
-
EPIC Successfully Completes Sale of EPIC Crude to Plains All American
-
TwoStep Therapeutics to Present at the 2025 SITC Annual Meeting
-
Coeur to Participate in RBC Capital Markets London Precious Metals Conference
-
Fifth Third Private Bank Named Best for Customer Service in North America for Second Year
-
Brookfield Infrastructure Reports Strong Third Quarter 2025 Results
-
K-Tech Rings the Closing Bell on the Nasdaq
-
Mobilicom Secures Follow-On Production Order from Asia-Based Tier-1 Robotics Manufacturer Bringing Cumulative Orders to $315,000
-
GenVivo to Present Phase 1 Trial Results for GEN2, A Personalizing Systemic Cancer Immunotherapy, at the 2025 Society for Immunotherapy of Cancer (SITC) Annual Meeting
-
Inspired Announces Closing of Sale of UK Holiday Parks Business to Genda Inc.
-
HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
-
Akero Therapeutics Presents New Analyses from Phase 2b SYMMETRY and HARMONY Trials of Efruxifermin at 76th Annual AASLD The Liver Meeting® 2025
-
Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern’ Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio
-
AMC Networks Inc. Reports Third Quarter 2025 Results
-
RYTHM, Inc. Reports Third Quarter 2025 Results
-
Hain Celestial Reports Fiscal First Quarter 2026 Financial Results
